Yuanlong Li

ORCID: 0009-0004-5880-8448
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA modifications and cancer
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • MicroRNA in disease regulation
  • Lymphatic System and Diseases
  • NF-κB Signaling Pathways
  • Systemic Sclerosis and Related Diseases
  • Vascular Malformations and Hemangiomas
  • Immune cells in cancer
  • Computational Geometry and Mesh Generation
  • interferon and immune responses
  • Growth Hormone and Insulin-like Growth Factors
  • Electromagnetic Scattering and Analysis
  • Advanced Antenna and Metasurface Technologies
  • Glioma Diagnosis and Treatment
  • Metabolism and Genetic Disorders
  • Helicobacter pylori-related gastroenterology studies
  • Cancer Cells and Metastasis
  • Immune Response and Inflammation
  • Neurological Disease Mechanisms and Treatments
  • Ubiquitin and proteasome pathways
  • Genetic factors in colorectal cancer
  • Gastric Cancer Management and Outcomes
  • Circular RNAs in diseases
  • Cancer, Hypoxia, and Metabolism

Sun Yat-sen University
2013-2025

Southern Medical University
2025

Guangdong Provincial People's Hospital
2025

Guangdong Academy of Medical Sciences
2025

Wuhan University
2024

Sun Yat-sen Memorial Hospital
2023-2024

State Key Laboratory of Oncology in South China
2017-2024

Key Laboratory of Guangdong Province
2017

Cancer-associated fibroblasts (CAFs) exhibit considerable heterogeneity in advanced cancers; however, the functional annotation and mechanism of CAFs early-stage cancers remain elusive. Utilizing single-cell RNA sequencing spatial transcriptomic, we identify a previously unknown PDGFRα+ITGA11+ CAF subset bladder cancer (BCa). Multicenter clinical analysis 910-case cohort confirms that are associated with lymphovascular invasion (LVI) poor prognosis BCa. These facilitate LVI lymph node (LN)...

10.1016/j.ccell.2024.02.002 article EN cc-by-nc Cancer Cell 2024-02-29

Abstract Heterogeneous extracellular vesicles (EVs) from various types of tumours are acknowledged for inducing the formation pre‐metastatic “niches” in draining lymph nodes (LNs) to promote lymphatic metastasis. In order identify specific subpopulations EVs involved, we performed high‐resolution proteomic analysis combined with nanoflow cytometry bladder cancer (BCa) tissue‐derived a novel subset tumour‐derived that contain integrin α6 (ITGA6 + EVs) and revealed positive correlation ITGA6...

10.1002/jev2.12518 article EN cc-by-nc-nd Journal of Extracellular Vesicles 2024-09-27

Intestinal farnesoid X receptor (FXR) antagonists have been proven to be efficacious in ameliorating metabolic diseases, particularly for the treatment of dysfunction-associated steatohepatitis (MASH). All reported FXR target ligand-binding pocket (LBP) receptor, whereas antagonist acting on non-LBP site nuclear (NR) is conceived as a promising strategy discover novel antagonist. Here, we postulated hypothesis antagonizing by disrupting interaction between and coactivators, successfully...

10.1093/lifemeta/loaf004 article EN cc-by Life Metabolism 2025-02-07

Background: Osteosarcopenia, the coexistence of osteoporosis and sarcopenia, poses significant challenges in aging populations due to its dual impact on bone muscle health. Inflammation, mediated by specific cytokines, is thought play a crucial role development osteosarcopenia, though underlying mechanisms are not fully understood. Objective: This study aimed clarify causal circulating cytokines pathogenesis osteosarcopenia employing mendelian randomization (MR) single-cell RNA sequencing...

10.1155/mi/6005225 article EN cc-by Mediators of Inflammation 2025-01-01

Abstract Aberrant gene expression is a prominent feature of metastatic cancer. Translational initiation vital step in fine-tuning expression. Thus, exploring translation regulators may identify therapeutic targets for preventing and treating metastasis. Herein, we identified that DHCR24 was overexpressed lymph node (LN) bladder cancer correlated with poor prognosis patients. promoted lymphangiogenesis LN metastasis vitro vivo. Mechanistically, mediated recognized the SUMO2 modification at...

10.1158/0008-5472.can-23-2278 article EN cc-by-nc-nd Cancer Research 2023-11-22

<div>Abstract<p>Aberrant gene expression is a prominent feature of metastatic cancer. Translational initiation vital step in fine-tuning expression. Thus, exploring translation regulators may identify therapeutic targets for preventing and treating metastasis. Herein, we identified that DHCR24 was overexpressed lymph node (LN) bladder cancer correlated with poor prognosis patients. promoted lymphangiogenesis LN metastasis <i>in vitro</i> vivo</i>....

10.1158/0008-5472.c.7054207 preprint EN 2024-02-01

<div>Abstract<p>Aberrant gene expression is a prominent feature of metastatic cancer. Translational initiation vital step in fine-tuning expression. Thus, exploring translation regulators may identify therapeutic targets for preventing and treating metastasis. Herein, we identified that DHCR24 was overexpressed lymph node (LN) bladder cancer correlated with poor prognosis patients. promoted lymphangiogenesis LN metastasis <i>in vitro</i> vivo</i>....

10.1158/0008-5472.c.7054207.v1 preprint EN 2024-02-01
Coming Soon ...